Should I buy or sell IM Cannabis stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for IM Cannabis in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" IMCC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in IMCC, but not buy additional shares or sell existing shares. View IMCC analyst ratings or view top-rated stocks .

How have IMCC shares performed in 2023?

IM Cannabis' stock was trading at $0.9748 at the start of the year. Since then, IMCC shares have decreased by 58.5% and is now trading at $0.4049. View the best growth stocks for 2023 here .

Are investors shorting IM Cannabis?

IM Cannabis saw a drop in short interest during the month of November. As of November 15th, there was short interest totaling 1,700 shares, a drop of 89.2% from the October 31st total of 15,800 shares. Based on an average daily trading volume, of 63,400 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.0% of the shares of the stock are short sold. View IM Cannabis' Short Interest .

When is IM Cannabis' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 3rd 2024. View our IMCC earnings forecast .

When did IM Cannabis' stock split?

IM Cannabis's stock reverse split on Wednesday, November 16th 2022. The 1-10 reverse split was announced on Wednesday, November 16th 2022. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, November 16th 2022. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Who are IM Cannabis' major shareholders?

IM Cannabis' stock is owned by many different institutional and retail investors. Top institutional investors include Lynwood Capital Management Inc. (4.85%) and Concourse Financial Group Securities Inc. (0.00%).

How do I buy shares of IM Cannabis?

Shares of IMCC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

IM Cannabis Stock Price, News & Analysis (NASDAQ:IMCC)

$0.40

-0.01 (-1.48%)

(As of 05:28 PM ET)

Compare

Today's Range: $0.39
▼
$0.44
50-Day Range: $0.39
▼
$0.69
52-Week Range: $0.37
▼
$2.14

Volume: 35,087 shs
Average Volume: 71,109 shs
Market Capitalization: $5.42 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About IM Cannabis Stock (NASDAQ:IMCC)

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands. The company serves medical patients. IM Cannabis Corp. is headquartered in Tel Aviv, Israel.

IMCC Stock Price History

30 days | 90 days | 365 days | Advanced Chart

IMCC Stock News Headlines

November 8, 2023 | finance.yahoo.com

IM Cannabis to Report Third Quarter 2023 Financial Results on Monday, November 13 at 9:00am ET

October 10, 2023 | finanznachrichten.de

IM Cannabis Corp.: IM Cannabis Announces the appointment of Uri Birenberg as Chief Financial Officer

December 4, 2023 | Wealthpress (Ad)

Trading Experts Call It “The Perfect Tesla Trade”

Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.

October 10, 2023 | finance.yahoo.com

IM Cannabis Announces the appointment of Uri Birenberg as Chief Financial Officer

October 6, 2023 | cbsnews.com

Michigan man growing cannabis worth millions won't face major charges, court says

September 25, 2023 | msn.com

"We got this wrong:" Minnesota's first legal cannabis director quits after one day

September 12, 2023 | msn.com

Mum defends decision to smoke medical marijuana while pregnant

August 8, 2023 | finance.yahoo.com

IM Cannabis to Report Second Quarter 2023 Financial Results on Monday, August 14 at 9:00am ET

December 4, 2023 | Wealthpress (Ad)

Trading Experts Call It “The Perfect Tesla Trade”

August 7, 2023 | benzinga.com

International Medical Marijuana Operator Gets NASDAQ Warning As Stock Price Drops Below $1

August 1, 2023 | msn.com

Owner of "I'm Stuck" cannabis stores speaks out on allegations amidst closures

July 12, 2023 | benzinga.com

'Bipartisan Lawmakers Push For Marijuana And Psychedelics Amendments To Defense Bill, But Committee Action Is Delayed' - Marijuana Moment

July 10, 2023 | benzinga.com

'Schumer Says Passing Marijuana Banking Bill 'Will Not Be Easy' And Needs GOP Support, As He Sets Agenda For Summer' - Marijuana Moment

June 13, 2023 | msn.com

Samuel Adams Founders With A THC Drink - $GLASF $VRNOF $SBIG $IMCC $CWBHF

March 29, 2023 | finance.yahoo.com

IM Cannabis Reports Fourth Quarter and Fiscal Year 2022 Financial Results; Revenues in 2022 Increased 60% Year-over-Year

March 28, 2023 | msn.com

Preview: IM Cannabis's Earnings

March 15, 2023 | finance.yahoo.com

IM Cannabis to Report Fourth Quarter & Full Year 2022 Financial Results on Wednesday, March 29 at 9:00am ET

March 10, 2023 | markets.businessinsider.com

Atlas Global Brands Makes Changes 'Not Taken Lightly' - Reduces Its Workforce By ~20%

February 13, 2023 | finanznachrichten.de

IM Cannabis Corp.: IM Cannabis Provides an Update on Panaxia Transaction

February 13, 2023 | finance.yahoo.com

IM Cannabis Provides an Update on Panaxia Transaction

February 7, 2023 | finanznachrichten.de

IM Cannabis Corp.: IM Cannabis Closes Additional Tranches of Private Placement Offerings

February 7, 2023 | finance.yahoo.com

IM Cannabis Closes Additional Tranches of Private Placement Offerings

January 27, 2023 | finance.yahoo.com

IM Cannabis Provides Update to Listed Issuer Financing Exemption Offering

January 17, 2023 | finance.yahoo.com

RAFAEL GABAY ACQUIRES SECURITIES OF IM CANNABIS CORP.

January 17, 2023 | finance.yahoo.com

OREN SHUSTER ACQUIRES SECURITIES OF IM CANNABIS CORP.

January 11, 2023 | benzinga.com

'Minnesota's Governor Wants People To Sign A Marijuana Petition Asking Lawmakers To Put Legalization On His Desk' - Marijuana Moment

January 3, 2023 | msn.com

Hybrid Dispensaries Ready for Cannabis Sales in Conn.

See More Headlines

Receive IMCC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IM Cannabis and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 12/04/2023
Fiscal Year End: 12/31/2023
Next Earnings (Estimated): 4/03/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Medicinals & botanicals
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:IMCC
CUSIP: N/A
CIK: 1792030
Web: www.imcannabis.com
Phone: 972-54-433-1111
Fax: N/A
Employees: 283
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-145,290,000.00
Net Margins: N/A
Pretax Margin: 13.20%
Return on Equity: 21.99%
Return on Assets: 8.74%

Debt

Debt-to-Equity Ratio: 0.02
Current Ratio: 1.01
Quick Ratio: 0.62

Sales & Book Value

Annual Sales: $41.79 million
Price / Sales: 0.13
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $2.42 per share
Price / Book: 0.17

Miscellaneous

Outstanding Shares: 13,390,000
Free Float: N/A
Market Cap: $5.42 million
Optionable: Not Optionable
Beta: 0.70

(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

Mr. Marc Lustig M.B.A. (Age 49)
M.Sc., Executive Chairman
Comp: $204.65k
Mr. Oren Shuster
CEO & Director
Mr. Richard Balla
CEO & Director of German Operations Adjupharm GmbH
Mr. Michael Ruscetta (Age 54)
Chief Executive Officer of Trichome Financial Corp.
Comp: $93.09k
Mr. Howard Steinberg C.F.A. (Age 58)
Chief Executive Officer of TJAC & MYM
Comp: $510.52k
Ms. Rinat Efrima (Age 46)
Chief Executive Officer of IMC Holdings Ltd.
Mr. Uri Birenberg (Age 47)
Chief Financial Officer
Advocate Michal Lebovitz Nissimov
General Counsel
Mr. Itay Vago
Executive Officer

Key Competitors

View All Competitors

Institutional Ownership

Lynwood Capital Management Inc.
Bought 100,000 shares on 11/1/2023
Ownership: 4.854%

View All Institutional Transactions

IMCC Stock Analysis - Frequently Asked Questions

Should I buy or sell IM Cannabis stock right now?: 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for IM Cannabis in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" IMCC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in IMCC, but not buy additional shares or sell existing shares.
View IMCC analyst ratings or view top-rated stocks.
How have IMCC shares performed in 2023?: IM Cannabis' stock was trading at $0.9748 at the start of the year. Since then, IMCC shares have decreased by 58.5% and is now trading at $0.4049.
View the best growth stocks for 2023 here.
Are investors shorting IM Cannabis?: IM Cannabis saw a drop in short interest during the month of November. As of November 15th, there was short interest totaling 1,700 shares, a drop of 89.2% from the October 31st total of 15,800 shares. Based on an average daily trading volume, of 63,400 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.0% of the shares of the stock are short sold.
View IM Cannabis' Short Interest.
When is IM Cannabis' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 3rd 2024.
View our IMCC earnings forecast.

When did IM Cannabis' stock split?: IM Cannabis's stock reverse split on Wednesday, November 16th 2022. The 1-10 reverse split was announced on Wednesday, November 16th 2022. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, November 16th 2022. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.
Who are IM Cannabis' major shareholders?: IM Cannabis' stock is owned by many different institutional and retail investors. Top institutional investors include Lynwood Capital Management Inc. (4.85%) and Concourse Financial Group Securities Inc. (0.00%).
How do I buy shares of IM Cannabis?: Shares of IMCC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:IMCC) was last updated on 12/4/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial